Literature DB >> 12388353

Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells.

Susan J Smith1, Steven Brookes-Fazakerley, Louise E Donnelly, Peter J Barnes, Mary S Barnette, Mark A Giembycz.   

Abstract

We have determined the expression of phosphodiesterase (PDE) 7A1 and PDE7A2 in human cells that have been implicated in the pathogenesis of chronic obstructive pulmonary disease and asthma. Messenger RNA transcripts were detected by RT-PCR in T lymphocytes, monocytes, neutrophils, airway and vascular smooth muscle cells, lung fibroblasts, epithelial cells, and cardiac myocytes. Human epithelial, T cell, eosinophil, and lung fibroblast cell lines were also positive for PDE7A1 and PDE7A2 mRNA transcripts. By Western immunoblot analyses the amount of PDE7A1 was greatest in T cell lines, peripheral blood T lymphocytes, epithelial cell lines, airway and vascular smooth muscle cells, lung fibroblasts, and eosinophils but was not detected in neutrophils. In contrast, PDE7A2 protein, which was identified in human cardiac myocytes, was not found in any of the other cell types investigated. Immunoconfocal analyses showed that PDE7A was expressed in neutrophils and alveolar macrophages. As the expression of PDE7A mirrors the distribution of PDE4 we speculate that this enzyme could be a target for novel anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388353     DOI: 10.1152/ajplung.00170.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  26 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 2.  PDE4 inhibitors: current status.

Authors:  D Spina
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

3.  Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.

Authors:  C J Busch; A R Graveline; K Jiramongkolchai; H Liu; L S Sanchez; K D Bloch
Journal:  J Physiol Pharmacol       Date:  2010-12       Impact factor: 3.011

4.  Inhibition of superoxide anion and elastase release in human neutrophils by 3'-isopropoxychalcone via a cAMP-dependent pathway.

Authors:  Tsong-Long Hwang; Shang-Hsin Yeh; Yann-Lii Leu; Ching-Yuh Chern; Hui-Chi Hsu
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

5.  Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells.

Authors:  Nahid Eskandari; Fatemeh Tashrifi; Reza Bastan; Alrieza Andalib; Zahra Yousefi; Peter T Peachell
Journal:  Int J Immunopathol Pharmacol       Date:  2016-01-18       Impact factor: 3.219

Review 6.  Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases.

Authors:  Martina Schmidt; Isabella Cattani-Cavalieri; Francisco J Nuñez; Rennolds S Ostrom
Journal:  Curr Opin Pharmacol       Date:  2020-07-01       Impact factor: 5.547

Review 7.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

8.  New classes of PDE7 inhibitors identified by a fission yeast-based HTS.

Authors:  Manal A Alaamery; Arlene R Wyman; F Douglas Ivey; Christina Allain; Didem Demirbas; Lili Wang; Ozge Ceyhan; Charles S Hoffman
Journal:  J Biomol Screen       Date:  2010-03-12

9.  Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.

Authors:  Lingzhi Zhang; Fiona Murray; Anja Zahno; Joan R Kanter; Daisy Chou; Ryan Suda; Michael Fenlon; Laura Rassenti; Howard Cottam; Thomas J Kipps; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.